연구성과로 돌아가기
JCR 2024 저널 목록 (1390 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Advances in Biological Regulation | ELSEVIER | 2212-4926 | 2212-4934 | ESCI | BIOCHEMISTRY & MOLECULAR BIOLOGY | 1,322 | 2.4 | Q3 | 71.0 | 29.0 | 227/319 | N/A | N/A | 2.3 | 0.8 | 0.62 | 176/320 | Q3 | 45.16 | 0.001 | 0.296 | N/A | N/A | 26 | 96.2% | 6.6 | 11.7 | 25 | 35.6% | 2025-08-05 16:02:33 | 바로가기 |
| AMINO ACIDS | SPRINGER WIEN | 0939-4451 | 1438-2199 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 10,439 | 2.4 | Q3 | 71.0 | 29.0 | 227/319 | 3.1 | Q3 | 2.4 | 0.7 | 0.56 | 205/320 | Q3 | 36.09 | 0.004 | 0.788 | 0.652 | Q3 | 72 | 86.1% | 11.1 | 7.7 | 62 | 40.9% | 2025-08-05 16:02:32 | 바로가기 |
| BIOLOGICAL CHEMISTRY | WALTER DE GRUYTER GMBH | 1431-6730 | 1437-4315 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 6,346 | 2.4 | Q3 | 71.0 | 29.0 | 227/319 | 3.2 | Q3 | 2.4 | 0.9 | 0.42 | 259/320 | Q4 | 19.22 | 0.004 | 0.926 | 0.983 | Q2 | 35 | 71.4% | 10.5 | 9.1 | 25 | 38.7% | 2025-08-05 16:02:32 | 바로가기 |
| Breast Journal | WILEY | 1075-122X | 1524-4741 | SCIE | ONCOLOGY | 3,296 | 2.0 | Q3 | 71.0 | 29.0 | 232/326 | 2.1 | Q3 | 2.0 | 0.4 | 0.47 | 221/326 | Q3 | 32.36 | 0.003 | 0.602 | 0.573 | Q3 | 34 | 82.4% | 7.8 | 7.3 | 28 | 99.0% | 2025-08-05 16:04:24 | 바로가기 |
| Cancer Innovation | WILEY | 2770-9191 | 2770-9183 | ESCI | ONCOLOGY | 161 | 2.0 | Q3 | 71.0 | 29.0 | 232/326 | 2.0 | Q4 | 1.9 | 0.6 | 0.38 | 247/326 | Q4 | 24.39 | 0.000 | 0.057 | 0.477 | Q4 | 47 | 63.8% | 1.6 | 5.9 | 30 | 97.4% | 2025-08-05 16:04:25 | 바로가기 |
| Comparative Biochemistry and Physiology D-Genomics & Proteomics | ELSEVIER SCIENCE INC | 1744-117X | 1878-0407 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 2,158 | 2.4 | Q3 | 71.0 | 29.0 | 227/319 | 2.8 | Q3 | 2.1 | 0.4 | 0.62 | 176/320 | Q3 | 45.16 | 0.002 | 0.449 | 0.524 | Q3 | 177 | 98.9% | 4.7 | 8.1 | 175 | 6.1% | 2025-08-05 16:02:32 | 바로가기 |
| Familial Cancer | SPRINGER | 1389-9600 | 1573-7292 | SCIE | ONCOLOGY | 1,831 | 2.0 | Q3 | 71.0 | 29.0 | 232/326 | 2.3 | Q3 | 1.9 | 0.8 | 0.48 | 220/326 | Q3 | 32.67 | 0.002 | 0.407 | 0.949 | Q2 | 64 | 54.7% | 8.5 | 6.3 | 35 | 46.8% | 2025-08-05 16:04:25 | 바로가기 |
| INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | SAGE PUBLICATIONS LTD | 0393-6155 | 1724-6008 | SCIE | ONCOLOGY | 1,263 | 2.0 | Q3 | 71.0 | 29.0 | 232/326 | 2.0 | Q4 | 2.0 | 0.6 | 0.46 | 224/326 | Q3 | 31.44 | 0.001 | 0.152 | 0.407 | Q4 | 29 | 96.6% | 7.6 | 5.5 | 28 | 99.0% | 2025-08-05 16:04:25 | 바로가기 |
| International Journal of Particle Therapy | ELSEVIER | N/A | 2331-5180 | ESCI | ONCOLOGY | 587 | 2.0 | Q3 | 71.0 | 29.0 | 232/326 | 2.3 | Q3 | 2.0 | 0.8 | 0.52 | 205/326 | Q3 | 37.27 | 0.001 | 0.166 | 0.652 | Q3 | 54 | 98.2% | 3.9 | 7.5 | 53 | 98.8% | 2025-08-05 16:04:25 | 바로가기 |
| International Journal of Peptide Research and Therapeutics | SPRINGER | 1573-3149 | 1573-3904 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 2,331 | 2.4 | Q3 | 71.0 | 29.0 | 227/319 | 2.0 | Q4 | 2.3 | 0.5 | 0.46 | 246/320 | Q4 | 23.28 | 0.002 | 0.503 | 0.316 | Q4 | 84 | 73.8% | 4.3 | 7.7 | 62 | 8.6% | 2025-08-05 16:02:32 | 바로가기 |
| JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS | TAYLOR & FRANCIS INC | 0739-1102 | 1538-0254 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 15,253 | 2.4 | Q3 | 71.0 | 29.0 | 227/319 | 2.7 | Q3 | 2.2 | 0.8 | 0.66 | 165/320 | Q3 | 48.59 | 0.014 | 3.078 | 0.376 | Q4 | 548 | 98.4% | 3.9 | 8.1 | 539 | 2.2% | 2025-08-05 16:02:32 | 바로가기 |
| Journal of Breast Imaging | OXFORD UNIV PRESS | 2631-6110 | 2631-6129 | ESCI | ONCOLOGY | 729 | 2.0 | Q3 | 71.0 | 29.0 | 232/326 | 1.9 | Q4 | 1.6 | 0.7 | 0.50 | 216/326 | Q3 | 33.90 | 0.002 | 0.346 | 0.568 | Q3 | 92 | 75.0% | 3.1 | 7.8 | 69 | 9.1% | 2025-08-05 16:04:25 | 바로가기 |
| Journal of Gastrointestinal Oncology | AME PUBLISHING COMPANY | 2078-6891 | 2219-679X | SCIE | ONCOLOGY | 4,128 | 2.0 | Q3 | 71.0 | 29.0 | 232/326 | 2.3 | Q3 | 1.9 | 0.4 | 0.45 | 229/326 | Q3 | 29.91 | 0.005 | 1.131 | 0.586 | Q3 | 215 | 93.5% | 4.7 | 5.0 | 201 | 99.2% | 2025-08-05 16:04:24 | 바로가기 |
| JOURNAL OF RADIATION RESEARCH | OXFORD UNIV PRESS | 0449-3060 | 1349-9157 | SCIE | ONCOLOGY | 3,552 | 2.0 | Q3 | 71.0 | 29.0 | 232/326 | 2.2 | Q3 | 1.8 | 0.4 | 0.54 | 199/326 | Q3 | 39.11 | 0.002 | 0.538 | 0.521 | Q3 | 100 | 95.0% | 7.8 | 7.9 | 95 | 92.1% | 2025-08-05 16:04:24 | 바로가기 |
| Molecular Omics | ROYAL SOC CHEMISTRY | N/A | 2515-4184 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 1,027 | 2.4 | Q3 | 71.0 | 29.0 | 227/319 | 3.0 | Q3 | 2.3 | 0.6 | 0.50 | 232/320 | Q3 | 27.66 | 0.002 | 0.440 | 0.792 | Q2 | 46 | 82.6% | 3.5 | 6.6 | 38 | 15.2% | 2025-08-05 16:02:33 | 바로가기 |
페이지 이동: